CurrentEndo
Get Weekly

CurrentEndo coverage · page 45 of 55

Diabetes, Obesity and Metabolism

Briefs 1,761–1,800 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

  1. Diabetes Obes Metab

    Efficacy and safety of intragastric expandable oral capsules in adults with overweight or obesity: A randomized, double‐blind, placebo‐controlled trial

    Randomized controlled trialObesity

  2. Diabetes Obes Metab

    Intermediate versus morning chronotype has lower vascular insulin sensitivity in adults with obesity

    Cross-sectional studyObesity

  3. Diabetes Obes Metab

    Adherence to liraglutide among individuals with overweight and obesity: Patient characteristics and clinical measures

    Cohort studyObesity

  4. Diabetes Obes Metab

    Sex‐ and time‐specific associations of obesity with glycaemic traits: A two‐step multivariate Mendelian randomization study

    Research articleObesity

  5. Diabetes Obes Metab

    Sodium‐glucose co‐transporter 2 inhibitor therapy reduces the administration frequency of anti‐vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti‐vascular endothelial growth factor agent use: A cohort study using the Japanese health insurance claims database

    Cohort studyComplications

  6. Diabetes Obes Metab

    Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32‐week randomized trial

    Randomized controlled trialT2D & other

  7. Diabetes Obes Metab

    Liver, renal, genitourinary and diabetic ketoacidosis risks among new users of empagliflozin versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: Post‐authorization safety study based on multinational cohorts

    Cohort studyT2D & other

  8. Diabetes Obes Metab

    Two years with GIOIA ‘Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes’: A prospective, multicentre, quasi‐experimental study on sodium‐glucose cotransporter 2 and dipeptidyl peptidase‐4 inhibitors in diabetes clinical practice

    Cohort studyT2D & other

  9. Diabetes Obes Metab

    Effect of intermittently scanned continuous glucose monitoring in people with diabetes with a psychosocial indication for initiation

    Research articleTechnology

  10. Diabetes Obes Metab

    Adaptive infusion of a glucagon‐like peptide‐1/glucagon receptor co‐agonist G3215 , in adults with overweight or obesity: Results from a phase 1 randomized clinical trial

    Randomized controlled trialObesity

  11. Diabetes Obes Metab

    Real‐world use of glucagon‐like peptide‐1 receptor agonists in youth with type 2 diabetes is associated with short‐term improvements in HbA1c

    Cohort studyT2D & other

  12. Diabetes Obes Metab

    REduced‐Carbohydrate intervention for managing Obesity and Reduction of gestational Diabetes ( RECORD ): A randomized controlled feasibility trial

    Randomized controlled trialDiabetes in pregnancy

  13. Diabetes Obes Metab

    Risk factor control and incident cardiovascular disease in patients with diabetes: Sex‐specific relations

    Cohort studyT2D & other

  14. Diabetes Obes Metab

    Socio‐economic disparities in hospital care among Dutch patients with diabetes mellitus

    Cohort studyT2D & other

  15. Diabetes Obes Metab

    Pre‐exercise protein intake is associated with reduced time in hypoglycaemia among adolescents with type 1 diabetes

    Secondary analysisT1D

  16. Diabetes Obes Metab

    Prusogliptin ( DBPR108 ) monotherapy in treatment‐naïve patients with type 2 diabetes: A randomized, double‐blind, active and placebo‐controlled, phase 3 study

    Randomized controlled trialT2D & other

  17. Diabetes Obes Metab

    First‐in‐human study of CPL207280 , a novel G‐protein‐coupled receptor 40/free fatty acid receptor 1 agonist, in healthy volunteers after single and multiple administration

    Cohort studyT2D & other

  18. Diabetes Obes Metab

    Validation of an international classification of disease, tenth revision, clinical modification ( ICD‐10‐CM ) algorithm in identifying severe hypoglycaemia events for real‐world studies

    Diagnostic or prognostic studyComplications

  19. Diabetes Obes Metab

    Effect of basal insulin and omega 3 fatty acids on cognitive impairment in dysglycaemia: An exploratory analysis of the ORIGIN trial

    Secondary analysisT2D & other

  20. Diabetes Obes Metab

    Treatment effect of semaglutide 2.4 mg on health‐related quality of life from STEP 1 SF‐6D derived from SF ‐36 with Australian weights

    Secondary analysisObesity

  21. Diabetes Obes Metab

    Efficacy and safety of once‐weekly insulin icodec in type 2 diabetes: A meta‐analysis of ONWARDS phase 3 randomized controlled trials

    Meta-analysisT2D & other

  22. Diabetes Obes Metab

    Comparative effectiveness of sodium‐glucose cotransporter‐2 inhibitors versus glucagon‐like peptide‐1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease

    Cohort studyT2D & other

  23. Diabetes Obes Metab

    Twenty‐four‐hour physical behaviour profiles across type 2 diabetes mellitus subtypes

    Cross-sectional studyT2D & other

  24. Diabetes Obes Metab

    Glucose sensor with predictive alarm for hypoglycaemia: Improved glycaemic control in adolescents with type 1 diabetes

    Randomized controlled trialT1D

  25. Diabetes Obes Metab

    Effects of age and disease duration on the efficacy and safety of iGlarLixi in Asian people with type 2 diabetes: A post hoc analysis of the LixiLan‐O‐AP and LixiLan‐L‐CN trials

    Secondary analysisT2D & other

  26. Diabetes Obes Metab

    Associations between Chinese visceral adiposity index and risks of all‐cause and cause‐specific mortality: A population‐based cohort study

    Cohort study

  27. Diabetes Obes Metab

    Clinical features of type 1 diabetes in older adults and the impact of intermittently scanned continuous glucose monitoring: An Association of British Clinical Diabetologists (ABCD) study

    Cohort studyTechnology

  28. Diabetes Obes Metab

    Patterns of metformin use and glycated haemoglobin trends among patients with newly diagnosed type 2 diabetes in Alberta, Canada

    Cohort studyT2D & other

  29. Diabetes Obes Metab

    Influence of a diet and/or exercise intervention on long‐term mortality and vascular complications in people with impaired glucose tolerance: Da Qing Diabetes Prevention Outcome study

    Randomized controlled trialT2D & other

  30. Diabetes Obes Metab

    Elucidating the glucose‐lowering effect of the bile acid sequestrant sevelamer

    Randomized controlled trialT2D & other

  31. Diabetes Obes Metab

    Meta‐analysis of risk of major adverse cardiovascular events in adults with type 2 diabetes treated with bexagliflozin

    Meta-analysisT2D & other

  32. Diabetes Obes Metab

    The MiniMed 780G automated insulin delivery system adapts to substantial changes in daily routine: Lessons from real world users during Ramadan

    Cohort studyTechnology

  33. Diabetes Obes Metab

    Glycated haemoglobin, HOMA2‐B , C‐peptide to glucose ratio and type 2 diabetes clusters as predictors for therapy failure in individuals with type 2 diabetes without insulin therapy: A registry analysis

    Cohort studyT2D & other

  34. Diabetes Obes Metab

    G lucagon‐like peptide‐1 analogues in monogenic syndromic obesity: Real‐world data from a large cohort of Alström syndrome patients

    Cohort studyObesity

  35. Diabetes Obes Metab

    The impact of increased hepatic glucose production caused by empagliflozin on plasma glucose concentration in individuals with type 2 diabetes and nondiabetic individuals

    Randomized controlled trialT2D & other

  36. Diabetes Obes Metab

    Reduced incidence of diabetes during the COVID ‐19 pandemic in Alberta: A time‐segmented longitudinal study of Alberta's Tomorrow Project

    Cohort studyT2D & other

  37. Diabetes Obes Metab

    Impact of the diagnosis of gestational diabetes on maternal physical activity after pregnancy

    Cohort studyDiabetes in pregnancy

  38. Diabetes Obes Metab

    Effect of tirzepatide on albuminuria levels and renal function in patients with type 2 diabetes mellitus: A systematic review and multilevel meta‐analysis

    Meta-analysisComplications

  39. Diabetes Obes Metab

    Cardiovascular and renal outcomes with varying degrees of kidney disease in high‐risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE‐O trial

    Secondary analysisT2D & other

  40. Diabetes Obes Metab

    Future diabetes risk can be predicted by the number of abnormal oral glucose tolerance test values during pregnancy

    Cohort studyDiabetes in pregnancy

All 2,200 Briefs in ExploreShowing Briefs 1,761–1,800 of 2,200, newest first